Heart failure patients with depressed left ventricular ejection fraction
Conditions
Brief summary
Pulmonary blood pressure measured in mmhg and cardiac output measured in l / min at 3 months
Detailed description
Combined criteria for death or rehospitalization for heart failure at the beginning and end of each period, Scores observed in the EuroQoL-5D quality of life test at the beginning and end of each period., Scores observed in the 6-minute test at the beginning and end of each period, CA125, ST2, TnT and NTProBNP levels at the beginning and end of each period., Pulmonary congestion parameters by pulmonary ultrasound: B lines, Renal function parameters:% of glomerular filtrate or creatinine levels (mg / dl), hypotension (systolic blood pressure <100mmHg)., Adverse events resulting from the administration of the drug
Interventions
DRUGDOBUTAMINE
DRUGLEVOSIMENDAN
Sponsors
Instituto De Investigacion En Ciencias De La Salud Germans Trias I Pujol
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pulmonary blood pressure measured in mmhg and cardiac output measured in l / min at 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Combined criteria for death or rehospitalization for heart failure at the beginning and end of each period, Scores observed in the EuroQoL-5D quality of life test at the beginning and end of each period., Scores observed in the 6-minute test at the beginning and end of each period, CA125, ST2, TnT and NTProBNP levels at the beginning and end of each period., Pulmonary congestion parameters by pulmonary ultrasound: B lines, Renal function parameters:% of glomerular filtrate or creatinine levels (mg / dl), hypotension (systolic blood pressure <100mmHg)., Adverse events resulting from the administration of the drug | — |
Countries
Spain
Outcome results
None listed